017180.KO Myungmoon Phar

Healthcare Pharmaceuticals Korea Stock Exchange
1,104 KRW
Close of Nov 4, 2026
1,000 2,055
Market cap
KRW 37.5B
P/E
-
P/B
0.38x
ROE
-4.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 017180.KO undervalued?

Graham number

The Graham number of Myungmoon Phar cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Myungmoon Phar fundamental analysis

No fundamental analysis for Myungmoon Phar yet.

Myungmoon Phar stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Myungmoon Phar

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervo…

Full company profile